Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence

Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence

Introduction: The complex relationship between the microbiota-gut-brain axis (MGBA) and epilepsy has been increasingly investigated in preclinical studies. Conversely, evidence from clinical studies is still scarce. In recent years, the pivotal role of MGBA dysregulation in the pathophysiology of fu...

Full description

Bibliographic Details
Main Authors:	Federica Avorio, Emanuele Cerulli Irelli, Alessandra Morano, Martina Fanella, Biagio Orlando, Mariarita Albini, Luca M. Basili, Gabriele Ruffolo, Jinane Fattouch, Mario Manfredi, Emilio Russo, Pasquale Striano, Marilia Carabotti, Anna T. Giallonardo, Carola Severi, Carlo Di Bonaventura
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Neurology
Subjects:	gut-brain axis irritable bowel syndrome dysbiosis epilepsy drug-resistance functional gastrointestinal disorder
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2021.705126/full

Similar Items

Late-onset seizures and epilepsy: Electroclinical features suggestive of autoimmune etiology
by: Alessandra Morano, et al.
Published: (2022-08-01)

Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance
by: Emanuele Cerulli Irelli, et al.
Published: (2022-03-01)

Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial
by: Chiara Ricci, et al.
Published: (2022-10-01)

Irritable Bowel Syndrome: Role of Intestinal Microbiota Disorders and Ways of Their Correction
by: I.Ya. Budzak
Published: (2013-09-01)

Microbiota in Irritable Bowel Syndrome and Endometriosis: Birds of a Feather Flock Together—A Review
by: Noemi Salmeri, et al.
Published: (2023-08-01)

The role of probiotics in current algorithms for the treatment of irritable bowel syndrome: A review
by: Dmitry N. Andreev, et al.
Published: (2023-08-01)

A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy
by: Gabriele Ruffolo, et al.
Published: (2018-07-01)

Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study
by: Fernando Rizzello, et al.
Published: (2018-12-01)

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects
by: Morano A, et al.
Published: (2020-02-01)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
by: Alessandra Lo Presti, et al.
Published: (2019-07-01)

COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01)

The role of the gut microbiota in understanding functional gastrointestinal disorders
by: Witold Zardzewiały, et al.
Published: (2023-08-01)

EEG Markers of Treatment Resistance in Idiopathic Generalized Epilepsy: From Standard EEG Findings to Advanced Signal Analysis
by: Emanuele Cerulli Irelli, et al.
Published: (2022-09-01)

Chronic Gut Inflammation and Dysbiosis in IBS: Unraveling Their Contribution to Atopic Dermatitis Progression
by: Jae-Hwan Jang, et al.
Published: (2024-02-01)

Corrigendum: Managing symptom profile of IBS-D patients with Tritordeum-based foods: results from a pilot study
by: Francesco Russo, et al.
Published: (2023-04-01)

Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study
by: Francesco Russo, et al.
Published: (2022-02-01)

The role of the gut microbiota and the use of new therapies in Irritable Bowel Syndrome
by: Jan Dąbrowski, et al.
Published: (2023-09-01)

Characteristics of the gut microbiota and the content of short-chain fatty acids in patients with irritable bowel syndrome
by: Yu.M. Stepanov, et al.
Published: (2019-09-01)

The role of the gut microbiome in paediatric irritable bowel syndrome
by: Alexandra S McHarg, et al.
Published: (2022-11-01)

Is microbiota characterization a useful tool in clinical practice? An exploratory analysis of patients from the IBS – constant-care e-health monitoring initiative
by: M. Qais Al-sheikh, et al.
Published: (2023-11-01)

Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis
by: Cecilia Ceccherini, et al.
Published: (2022-06-01)

Gut Microbiome and Lipidome Signatures in Irritable Bowel Syndrome Patients from a Low-Income, Food-Desert Area: A Pilot Study
by: Nikita Paripati, et al.
Published: (2023-10-01)

Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials
by: Chatpol Samuthpongtorn, et al.
Published: (2022-11-01)

Gut Microbiota Shifting in Irritable Bowel Syndrome: The Mysterious Role of Blastocystis sp.
by: Alireza Olyaiee, et al.
Published: (2022-06-01)

The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy
by: Pei Pei Chong, et al.
Published: (2019-06-01)

Corrigendum: The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy
by: Pei Pei Chong, et al.
Published: (2019-08-01)

Impact of 2′-Fucosyllactose on Gut Microbiota Composition in Adults with Chronic Gastrointestinal Conditions: Batch Culture Fermentation Model and Pilot Clinical Trial Findings
by: Jennifer Joan Ryan, et al.
Published: (2021-03-01)

Effects of Low and High FODMAP Diets on Human Gastrointestinal Microbiota Composition in Adults with Intestinal Diseases: A Systematic Review
by: Doris Vandeputte, et al.
Published: (2020-10-01)

Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain
by: Muhammad Nazirul Mubin Aziz, et al.
Published: (2021-08-01)

The microbiome of patients with irritable bowel syndrome: pathophysiology and applied aspects
by: N. V. Korochanskaya
Published: (2022-08-01)

Evaluation of gut microbiota of iranian patients with celiac disease, non-celiac wheat sensitivity, and irritable bowel syndrome: are there any similarities?
by: Kaveh Naseri, et al.
Published: (2023-01-01)

Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial
by: Sergii Tkach, et al.
Published: (2022-10-01)

Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation
by: Chunhua Zhou, et al.
Published: (2020-11-01)

Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of <i>Curcuma longa</i> and <i>Boswellia serrata</i> Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis
by: Attilio Giacosa, et al.
Published: (2022-01-01)

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update
by: Will Takakura, et al.
Published: (2020-07-01)

La simplificación de la acción administrativa
by: Cerulli Irelli
Published: (1997-06-01)

How to improve effectiveness of treatment of patients with irritable bowel syndrome?
by: E. V. Golovanova
Published: (2021-05-01)

Microbiota Alterations in Patients with Mucous Membrane Pemphigoid and Pemphigus Vulgaris: A Systematic Review
by: Rossella Santoro, et al.
Published: (2023-03-01)

Recent advances in understanding and managing diverticulitis [version 1; referees: 3 approved]
by: Carola Severi, et al.
Published: (2018-06-01)

Irritability to People: Typology and Mechanisms
by: Vladimir G. Maralov, et al.
Published: (2018-09-01)